Yahoo Finance 市场 全文
Is BioCryst’s (BCRX) Newest Approval Bigger Than It Looks?
Beneath the headline-driven sentiment of biotech investing lies the true engine of value creation: portfolio durability, capital efficiency, and sustainable revenue compounding. Founded on the promise of structure-based drug design…